4.11. Orthotopic Mouse Models of Breast Cancer

SS Salama A. Salama
CI Cristina Ivan
AE Abdelrahman M. Elsayed
CR Cristian Rodriguez-Aguayo
GL Gabriel Lopez-Berestein
request Request a Protocol
ask Ask a question
Favorite

We obtained five- to six-week-old female athymic nude mice (NCr nu/nu) from the Department of Experimental Radiation Oncology at The University of Texas MD Anderson Cancer Center (Houston, TX, USA). The mice were put in specific houses (5 per each) with standard acrylic glass cages in a room maintained at a recommended temperature and humidity with a 12 h light–dark cycle. They were supplied with a regular autoclaved chow diet with water ad libitum. For the experiments using MCF-7 and LCC2 cells, mice were primed with 17β-estradiol (Innovative Research of America, Sarasota, FL, USA) applied subcutaneously (0.32 mg estradiol/pellet) under the left shoulder to promote tumor growth. After 1 week, MCF-7 or LCC2 cells (6  ×  106) were orthotopically injected into the right mammary fat pad of each mouse. When the tumors were 3 to 5 mm, mice were divided into four groups and administered no treatment, tamoxifen (1 mg/100 µL/mouse intraperitoneally every 2 days for 2 weeks) [62]), THZ1 (10 mg/kg−1 body weight intraperitoneally once per day for 1 week) [63], or the combination of tamoxifen and THZ1 at the dosages described above. After 5 weeks of treatment, the animals were humanely killed, and tumors were removed and processed for further experiments. Tumor weight and volume were recorded. Tumor tissue was fixed in formalin for paraffin embedding and frozen in optimal cutting temperature medium to prepare frozen slides or snap-frozen for lysate preparation.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A